| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcc7df8a0744f77b99c4e99a5d0eaf0a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-10 |
| filingDate |
2006-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0057455cc028343308ed572fca8584ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac2c13a90e974d51f83ad7d04b470a83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5014a99d2335582e701c2ad9319d40fa |
| publicationDate |
2010-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2395286-C2 |
| titleOfInvention |
Pharmaceutical compositions containing conjugated estrogens and bazedoxifene |
| abstract |
FIELD: medicine. ^ SUBSTANCE: claimed invention relates to solid dosed compositions containing conjugated estrogens and bazedoxifene or bazedoxifene acetate. In accordance with some versions of invention realisation, said compositions contain core, which contains conjugated estrogens, and at least one envelope, which contains bazedoxifene or bazedoxifene acetate. ^ EFFECT: solid dosed composition in accordance with invention is intended for treatment of postmenopause symptoms and states with minimisation of proliferative effects in uterus and mammary gland. ^ 52 cl, 6 ex |
| priorityDate |
2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |